National Academies Press: OpenBook
« Previous: 9 Toward a Patient-Centered Strategy for Clinical Trials
Suggested Citation:"References." Institute of Medicine. 2012. Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13237.
×

References

ACGME (Accreditation Council for Graduate Medical Education). 2007. Common program requirements: General competencies. http://www.acgme.org/outcome/comp/GeneralCompetenciesStandards21307.pdf (accessed August 4, 2011).

Albritton, K. 2010. Elevating your online health brand. Capstrat Insights. http://www.capstrat.com/insights/blog/elevating-your-online-health-brand/ (accessed July 26, 2011).

Bickell, N. A., K. Shastri, K. Fei, S. Oluwole, H. Godfrey, K. Hiotis, A. Srinivasan, and A. A. Guth. 2008. A tracking and feedback registry to reduce racial disparities in breast cancer care. Journal of the National Cancer Institute 100(23):1717-1723.

CDC (Centers for Disease Control and Prevention). 2011. National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States. Atlanta, GA.

Christakis, N. A., and J. H. Fowler. 2007. The spread of obesity in a large social network over 32 years. New England Journal of Medicine 357(4):370-379.

Christakis, N. A., and J. H. Fowler. 2008. The collective dynamics of smoking in a large social network. New England Journal of Medicine 358(21):2249-2258.

Collins, F. S. 2011. Reengineering translational science: The time is right. Science Translational Medicine 3(90):90cm17.

Colucci, W. S. 2004. Landmark study: The carvedilol post-infarct survival control in left ventricular dysfunction study (CAPRICORN). American Journal of Cardiology 93(9 Suppl. 1):13-16.

Dorsey, E. R., J. de Roulet, J. P. Thompson, J. I. Reminick, A. Thai, Z. White-Stellato, C. A. Beck, B. P. George, and H, Moses III. 2010. Funding of US biomedical research, 2003-2008. Journal of the American Medical Association 303(2):137-143.

FDA (Food and Drug Administration). 2010. Advancing regulatory science for public health. http://www.fda.gov/ScienceResearch/SpecialTopics/RegulatoryScience/ucm228131.htm (accessed August 3, 2011).

FDA. 2011a. FY 2010 PDUFA financial report. http://www.fda.gov/AboutFDA/ReportsManualsForms/Reports/UserFeeReports/FinancialReports/PDUFA/ucm262838.htm (accessed July 20, 2011).

FDA. 2011b. FDA’s Sentinel Initiative. http://www.fda.gov/Safety/FDAsSentinelInitiative/default.htm (accessed July 19, 2011).

Suggested Citation:"References." Institute of Medicine. 2012. Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13237.
×

FDA. 2011c. Communicating risks and benefits: An evidence-based user’s guide. http://www.fda.gov/AboutFDA/ReportsManualsForms/Reports/ucm268078.htm (accessed September 13, 2011).

FDA. 2011d. Advancing regulatory science at FDA: A strategic plan. http://www.fda.gov/downloads/scienceresearch/specialtopics/regulatoryscience/ucm268225.pdf (accessed September 13, 2011).

Getz, K., J. Wenger, R. Campo, E. Seguine, and K. I. Kaitin. 2008. Assessing the impact of protocol design changes on clinical trial performance. American Journal of Therapeutics 15(5):450-457.

Goetz, T. 2010. Sergey Brin’s search for a Parkinson’s cure. Wired 18(7). http://www.wired.com/magazine/2010/06/ff_sergeys_search/all/1 (accessed July 28, 2011).

HHS (Department of Health and Human Services). 2011. Principles of community engagement. Second edition. NIH Pub. 11-7782. http://www.atsdr.cdc.gov/communityengagement (accessed August 5, 2011).

Horowitz, C., and N. A. Bickell. 2011. Diabetes and cancer clinical trials: Innovative community partnerships with diverse populations. Speaker presentation at the Institute of Medicine Workshop on Public Engagement and Clinical Trials: New Models and Disruptive Technologies, June 27, New York.

IOM (Institute of Medicine). 2004. Health literacy: A prescription to end confusion. Washington, DC: The National Academies Press.

IOM. 2007. Learning what works best. The nation’s need for evidence on comparative effectiveness in health care. http://www.iom.edu/~/media/Files/Activity%20Files/Quality/VSRT/ComparativeEffectivenessWhitePaperF.ashx (accessed July 18, 2011).

IOM. 2008. Learning healthcare system concepts v.2008: Annual report: The Roundtable of Evidence Based Medicine. http://iom.edu/Activities/Quality/~/media/1697E98CE25D4CAB8A10D9A4ABCB7091.pdf (accessed August 22, 2011).

IOM. 2010a. Transforming clinical research in the United States: Challenges and opportunities: Workshop summary. Washington, DC: The National Academies Press.

IOM. 2010b. A national cancer clinical trials system for the 21st century: Reinvigorating the NCI Cooperative Group Program. Washington, DC: The National Academies Press.

IOM. 2011. Relieving pain in America: A blueprint for transforming prevention, care, education, and research. Washington, DC: The National Academies Press.

Kuehn, B. M. 2011. Patients go online seeking support, practical advice on health conditions. Journal of the American Medical Association 305(16):1644-1645.

Kush, R. D. 2011. Transforming medical research with electronic health records. iHealth Connections 1(1):16-20.

Lilford, R. J., and J. Jackson. 1995. Equipoise and the ethics of randomization. Journal of the Royal Society of Medicine 88:552-559.

Maitland, K., S. Kiguli, R. O. Opoka, C. Engoru, P. Olupot-Olupot, S. O. Akech, R. Nyeko, G. Mtove, H. Reyburn, T. Lang, B. Brent, J. A. Evans, J. K. Tibenderana, J. Crawley, E. C. Russell, M. Levin, A. G. Babiker, and D. M. Gibb for the FEAST Trial Group. 2011. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine 364(26):2483-2495.

NCI (National Cancer Institute). 2010. NCI Cancer Bulletin. Special issue: Clinical trials enrollment. http://www.cancer.gov/ncicancerbulletin/051810/page5 (accessed September 27, 2011).

Neumann, J., J. Bras, E. Deas, S. O’Sullivan, L. Parkkinen, R. Lachmann, A. Li, J. Holton, R. Guerreiro, R. Paudel, B. Segarane, A. Singleton, A. Lees, J. Hardy, H. Houlden, T. Revesz, and N. W. Wood. 2009. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson’s disease. Brain 132:1783-1794.

NIH SMRB (National Institutes of Health Scientific Management Review Board). 2010. Report on the NIH Clinical Center. http://smrb.od.nih.gov/reports (accessed July 19, 2011).

Suggested Citation:"References." Institute of Medicine. 2012. Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13237.
×

O’Dell, J. R., C. E. Haire, N. Erikson, W. Drymalski, W. Palmer, P. J. Eckhoff, V. Garwood, P. Maloley, L. W. Klassen, S. Wees, H. Klein, and G. F. Moore. 1996. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. New England Journal of Medicine 334(20):1287-1291.

Partnership for Clear Health Communication. 2006. What is health literacy? npsf.org/pchc/health-literacy.php (accessed July 21, 2011).

Pew Internet and American Life Project. 2010. Older adults and social media. http://pewinternet.org/Reports/2010/Older-Adults-and-Social-Media.aspx (accessed July 26, 2011).

Ratzan, S. C., and R. M. Parker. 2000. Introduction. In National Library of Medicine current bibliographies in medicine: Health literacy. NLM Pub. CBM 2000-1, edited by C. R. Selden, M. Zorn, S. C. Ratzan, and R. M. Parker. Bethesda, MD: NIH, HHS.

Research!America. 2010. America speaks. Poll data summary, Volume 11. http://www.researchamerica.org/public_opinion (accessed August 3, 2011).

Resnik, D. B., and G. Koski. 2011. A national registry for healthy volunteers in phase 1 clinical trials. Commentary. Journal of the American Medical Association 305(12):1236-1237.

Roland, M., and D. J. Torgerson. 1998. Understanding controlled trials. What are pragmatic trials? British Medical Journal 316(7127):285. http://www.bmj.com/content/316/7127/285.extract (accessed July 18, 2011).

Rose, E. A., A. C. Gelijns, A. J. Moskowitz, D. F. Heitjan, L. W. Stevenson, W. Dembitsky, J. W. Long, D. D. Ascheim, A. R. Tierney, R. G. Levitan, J. T. Watson, and P. Meier for the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. 2001. Long-term use of a left ventricular assist device for end-stage heart failure. New England Journal of Medicine 345(20):1435-1443.

Sidransky E., M. A. Nalls, J. O. Aasly, J. Aharon-Peretz, G. Annesi, E. R. Barbosa, A. Bar-Shira, D. Berg, J. Bras, A. Brice, C.-M. Chen, L. N. Clark, C. Condroyer, E. V. De Marco, A. Durr, M. J. Eblan, S. Fahn, M. J. Farrer, H.-C. Fung, Z. Gan-Or, T. Gasser, R. Gershoni-Baruch, N. Giladi, A. Griffith, T. Gurevich, C. Januario, P. Kropp, A. E. Lang, G.-J. Lee-Chen, S. Lesage, K. Marder, I. F. Mata, A. Mirelman, J. Mitsui, I. Mizuta, G. Nicoletti, C. Oliveira, R. Ottman, A. Orr-Urtreger, L. V. Pereira, A. Quattrone, E. Rogaeva, A. Rolfs, H. Rosenbaum, R. Rozenberg, A. Samii, T. Samaddar, C. Schulte, M. Sharma, A. Singleton, M. Spitz, E.-K. Tan, N. Tayebi, T. Toda, A. R. Troiano, S. Tsuji, M. Wittstock, T. G. Wolfsberg, Y.-R. Wu, C. P. Zabetian, Y. Zhao, and S. G. Ziegler. 2009. Multicenter analysis of glucocerebrosidase mutations in Parkinson’s disease. New England Journal of Medicine 361(17):1651-1661.

Thaler, R. H. 2009. Opting in vs. opting out. New York Times, September 27. http://www.nytimes.com/2009/09/27/business/economy/27view.html (accessed July 26, 2011).

Tricoci, P., J. M. Allen, J. M. Kramer, R. M. Califf, and S. C. Smith, Jr. 2009. Scientific evidence underlying the ACC/AHA clinical practice guidelines. Journal of the American Medical Association 301(8):831-841.

Tunis, S. R., D. B. Stryer, and C. M. Clancy. 2003. Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. Journal of the American Medical Association 290:1624-1632.

Wanjek, C. 2008. ProtoType ready for PrimeTime. The NIH Catalyst, September-October. http://www.nih.gov/catalyst/2008/08.09.01/page01_prototype.html (accessed July 18, 2011).

Washington, H. A. 2006. Medical apartheid: The dark history of medical experimentation on black Americans from colonial times to the present. New York: Harlem Moon.

Zarcadoolas, C., A. F. Pleasant, and D. S. Greer. 2006. Advancing health literacy: A framework for understanding and action. Hoboken, NJ: John Wiley & Sons. http://books.google.com/books?id=vrUzjcPxHF0C&dq=Health%2BLiteracy&ie=ISO-8859-1&source=gbs_gdata (accessed July 27, 2011).

Suggested Citation:"References." Institute of Medicine. 2012. Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13237.
×

This page intentionally left blank.

Suggested Citation:"References." Institute of Medicine. 2012. Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13237.
×
Page85
Suggested Citation:"References." Institute of Medicine. 2012. Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13237.
×
Page86
Suggested Citation:"References." Institute of Medicine. 2012. Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13237.
×
Page87
Suggested Citation:"References." Institute of Medicine. 2012. Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13237.
×
Page88
Next: Appendix A: Workshop Agenda »
Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary Get This Book
×
Buy Paperback | $41.00 Buy Ebook | $32.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!